Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2
Squalene-based adjuvant compositions that can provide effective induction of specific humoral immune response have been developed. Recombinant receptor-binding domain (RBD) of surface S-protein of SARS-CoV-2 was used to evaluate the properties of the composition. Immunization of mice with the develo...
Gespeichert in:
| Veröffentlicht in: | Bulletin of experimental biology and medicine 2024-06, Vol.177 (2), p.221-224 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 224 |
|---|---|
| container_issue | 2 |
| container_start_page | 221 |
| container_title | Bulletin of experimental biology and medicine |
| container_volume | 177 |
| creator | Volosnikova, E. A. Volkova, N. V. Ermolaev, V. V. Borgoyakova, M. B. Nesmeyanova, V. S. Zaykovskaya, A. V. Pyankov, O. V. Zaitsev, B. N. Belenkaya, S. V. Isaeva, A. A. Shcherbakov, D. N. |
| description | Squalene-based adjuvant compositions that can provide effective induction of specific humoral immune response have been developed. Recombinant receptor-binding domain (RBD) of surface S-protein of SARS-CoV-2 was used to evaluate the properties of the composition. Immunization of mice with the developed squalene-based compositions in combination with RBD allows obtaining high titers of specific antibodies: from 10
5
to 2×10
6
. The blood sera from immunized mice exhibit neutralizing activity against SARS-CoV-2 Delta variant (B.1.617.2) with a titer up to 1:2000. |
| doi_str_mv | 10.1007/s10517-024-06160-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3087355206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3087355206</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-c12ecb676a225ef7a6509afb5685cf89c9e5e13e63cdbfaa340ca0972008da0b3</originalsourceid><addsrcrecordid>eNp90UFrFDEYBuAgFrtW_4AHCXjxEvslmWRmjutStVAquNZryGS-WbLMJttkRtBfb8atCh4KgRDy5E3IS8grDu84QH2ZOSheMxAVA801MP2ErLiqJWuE4E_JCopiVdM05-R5zvtlWeAzci5baGVVqxUJdxlpHOi638_fbZjoJh6OMfvJx5Dpe5uxpzHQ7f1sRwxIr0KeE2Z6HfrZLWg5fIvzlOzof_qwo-sw-S72viC7sz7kiW7XX7ZsE78x8YKcDXbM-PJhviB3H66-bj6xm88frzfrG-aE0hNzXKDrdK2tEAqH2moFrR06pRvlhqZ1LSrkErV0fTdYKytwFtpaADS9hU5ekLen3GOK9zPmyRx8djiONmCcs5HQ1FIpAbrQN__RfZxTKK8rqoUyKlUVJU7KpZhzwsEckz_Y9MNwMEsb5tSGKW2Y322YJfr1Q_TcHbD_e-TP9xcgTyCXrbDD9O_uR2J_ATnulOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090090454</pqid></control><display><type>article</type><title>Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2</title><source>SpringerLink Journals</source><creator>Volosnikova, E. A. ; Volkova, N. V. ; Ermolaev, V. V. ; Borgoyakova, M. B. ; Nesmeyanova, V. S. ; Zaykovskaya, A. V. ; Pyankov, O. V. ; Zaitsev, B. N. ; Belenkaya, S. V. ; Isaeva, A. A. ; Shcherbakov, D. N.</creator><creatorcontrib>Volosnikova, E. A. ; Volkova, N. V. ; Ermolaev, V. V. ; Borgoyakova, M. B. ; Nesmeyanova, V. S. ; Zaykovskaya, A. V. ; Pyankov, O. V. ; Zaitsev, B. N. ; Belenkaya, S. V. ; Isaeva, A. A. ; Shcherbakov, D. N.</creatorcontrib><description>Squalene-based adjuvant compositions that can provide effective induction of specific humoral immune response have been developed. Recombinant receptor-binding domain (RBD) of surface S-protein of SARS-CoV-2 was used to evaluate the properties of the composition. Immunization of mice with the developed squalene-based compositions in combination with RBD allows obtaining high titers of specific antibodies: from 10
5
to 2×10
6
. The blood sera from immunized mice exhibit neutralizing activity against SARS-CoV-2 Delta variant (B.1.617.2) with a titer up to 1:2000.</description><identifier>ISSN: 0007-4888</identifier><identifier>ISSN: 1573-8221</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-024-06160-6</identifier><identifier>PMID: 39093475</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adjuvants ; Aluminum ; Antibodies ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Immune response (humoral) ; Immunization ; Internal Medicine ; Laboratory animals ; Laboratory Medicine ; Particle size ; Pathology ; Pharmacology and Toxicology ; Protein composition ; Proteins ; Severe acute respiratory syndrome coronavirus 2 ; Squalene ; Toxicology ; Vaccines ; Virology</subject><ispartof>Bulletin of experimental biology and medicine, 2024-06, Vol.177 (2), p.221-224</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-c12ecb676a225ef7a6509afb5685cf89c9e5e13e63cdbfaa340ca0972008da0b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-024-06160-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-024-06160-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39093475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Volosnikova, E. A.</creatorcontrib><creatorcontrib>Volkova, N. V.</creatorcontrib><creatorcontrib>Ermolaev, V. V.</creatorcontrib><creatorcontrib>Borgoyakova, M. B.</creatorcontrib><creatorcontrib>Nesmeyanova, V. S.</creatorcontrib><creatorcontrib>Zaykovskaya, A. V.</creatorcontrib><creatorcontrib>Pyankov, O. V.</creatorcontrib><creatorcontrib>Zaitsev, B. N.</creatorcontrib><creatorcontrib>Belenkaya, S. V.</creatorcontrib><creatorcontrib>Isaeva, A. A.</creatorcontrib><creatorcontrib>Shcherbakov, D. N.</creatorcontrib><title>Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Squalene-based adjuvant compositions that can provide effective induction of specific humoral immune response have been developed. Recombinant receptor-binding domain (RBD) of surface S-protein of SARS-CoV-2 was used to evaluate the properties of the composition. Immunization of mice with the developed squalene-based compositions in combination with RBD allows obtaining high titers of specific antibodies: from 10
5
to 2×10
6
. The blood sera from immunized mice exhibit neutralizing activity against SARS-CoV-2 Delta variant (B.1.617.2) with a titer up to 1:2000.</description><subject>Adjuvants</subject><subject>Aluminum</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Immune response (humoral)</subject><subject>Immunization</subject><subject>Internal Medicine</subject><subject>Laboratory animals</subject><subject>Laboratory Medicine</subject><subject>Particle size</subject><subject>Pathology</subject><subject>Pharmacology and Toxicology</subject><subject>Protein composition</subject><subject>Proteins</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Squalene</subject><subject>Toxicology</subject><subject>Vaccines</subject><subject>Virology</subject><issn>0007-4888</issn><issn>1573-8221</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp90UFrFDEYBuAgFrtW_4AHCXjxEvslmWRmjutStVAquNZryGS-WbLMJttkRtBfb8atCh4KgRDy5E3IS8grDu84QH2ZOSheMxAVA801MP2ErLiqJWuE4E_JCopiVdM05-R5zvtlWeAzci5baGVVqxUJdxlpHOi638_fbZjoJh6OMfvJx5Dpe5uxpzHQ7f1sRwxIr0KeE2Z6HfrZLWg5fIvzlOzof_qwo-sw-S72viC7sz7kiW7XX7ZsE78x8YKcDXbM-PJhviB3H66-bj6xm88frzfrG-aE0hNzXKDrdK2tEAqH2moFrR06pRvlhqZ1LSrkErV0fTdYKytwFtpaADS9hU5ekLen3GOK9zPmyRx8djiONmCcs5HQ1FIpAbrQN__RfZxTKK8rqoUyKlUVJU7KpZhzwsEckz_Y9MNwMEsb5tSGKW2Y322YJfr1Q_TcHbD_e-TP9xcgTyCXrbDD9O_uR2J_ATnulOY</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Volosnikova, E. A.</creator><creator>Volkova, N. V.</creator><creator>Ermolaev, V. V.</creator><creator>Borgoyakova, M. B.</creator><creator>Nesmeyanova, V. S.</creator><creator>Zaykovskaya, A. V.</creator><creator>Pyankov, O. V.</creator><creator>Zaitsev, B. N.</creator><creator>Belenkaya, S. V.</creator><creator>Isaeva, A. A.</creator><creator>Shcherbakov, D. N.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20240601</creationdate><title>Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2</title><author>Volosnikova, E. A. ; Volkova, N. V. ; Ermolaev, V. V. ; Borgoyakova, M. B. ; Nesmeyanova, V. S. ; Zaykovskaya, A. V. ; Pyankov, O. V. ; Zaitsev, B. N. ; Belenkaya, S. V. ; Isaeva, A. A. ; Shcherbakov, D. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-c12ecb676a225ef7a6509afb5685cf89c9e5e13e63cdbfaa340ca0972008da0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adjuvants</topic><topic>Aluminum</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Immune response (humoral)</topic><topic>Immunization</topic><topic>Internal Medicine</topic><topic>Laboratory animals</topic><topic>Laboratory Medicine</topic><topic>Particle size</topic><topic>Pathology</topic><topic>Pharmacology and Toxicology</topic><topic>Protein composition</topic><topic>Proteins</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Squalene</topic><topic>Toxicology</topic><topic>Vaccines</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Volosnikova, E. A.</creatorcontrib><creatorcontrib>Volkova, N. V.</creatorcontrib><creatorcontrib>Ermolaev, V. V.</creatorcontrib><creatorcontrib>Borgoyakova, M. B.</creatorcontrib><creatorcontrib>Nesmeyanova, V. S.</creatorcontrib><creatorcontrib>Zaykovskaya, A. V.</creatorcontrib><creatorcontrib>Pyankov, O. V.</creatorcontrib><creatorcontrib>Zaitsev, B. N.</creatorcontrib><creatorcontrib>Belenkaya, S. V.</creatorcontrib><creatorcontrib>Isaeva, A. A.</creatorcontrib><creatorcontrib>Shcherbakov, D. N.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Volosnikova, E. A.</au><au>Volkova, N. V.</au><au>Ermolaev, V. V.</au><au>Borgoyakova, M. B.</au><au>Nesmeyanova, V. S.</au><au>Zaykovskaya, A. V.</au><au>Pyankov, O. V.</au><au>Zaitsev, B. N.</au><au>Belenkaya, S. V.</au><au>Isaeva, A. A.</au><au>Shcherbakov, D. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>177</volume><issue>2</issue><spage>221</spage><epage>224</epage><pages>221-224</pages><issn>0007-4888</issn><issn>1573-8221</issn><eissn>1573-8221</eissn><abstract>Squalene-based adjuvant compositions that can provide effective induction of specific humoral immune response have been developed. Recombinant receptor-binding domain (RBD) of surface S-protein of SARS-CoV-2 was used to evaluate the properties of the composition. Immunization of mice with the developed squalene-based compositions in combination with RBD allows obtaining high titers of specific antibodies: from 10
5
to 2×10
6
. The blood sera from immunized mice exhibit neutralizing activity against SARS-CoV-2 Delta variant (B.1.617.2) with a titer up to 1:2000.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39093475</pmid><doi>10.1007/s10517-024-06160-6</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-4888 |
| ispartof | Bulletin of experimental biology and medicine, 2024-06, Vol.177 (2), p.221-224 |
| issn | 0007-4888 1573-8221 1573-8221 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3087355206 |
| source | SpringerLink Journals |
| subjects | Adjuvants Aluminum Antibodies Antigens Biomedical and Life Sciences Biomedicine Cell Biology Immune response (humoral) Immunization Internal Medicine Laboratory animals Laboratory Medicine Particle size Pathology Pharmacology and Toxicology Protein composition Proteins Severe acute respiratory syndrome coronavirus 2 Squalene Toxicology Vaccines Virology |
| title | Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Adjuvant%20Compositions%20Based%20on%20Squalene%20Ensures%20Induction%20of%20Neutralizing%20Antibodies%20against%20SARS-CoV-2&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Volosnikova,%20E.%20A.&rft.date=2024-06-01&rft.volume=177&rft.issue=2&rft.spage=221&rft.epage=224&rft.pages=221-224&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-024-06160-6&rft_dat=%3Cproquest_cross%3E3087355206%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3090090454&rft_id=info:pmid/39093475&rfr_iscdi=true |